Pharmaceutical Stability
Pharmaceutical Stability - Related Videos
01:22
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
0 Views •
2025
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
07:00
Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
0 Views •
Cited by 2 •
2017
The lack of a well-defined procedure that consistently cleaned coupon surfaces was identified as the major contributor to low and variable recoveries in cleaning verification. This manuscript describes the correct protocol of cleaning stainless steel coupons.
01:26
Pharmaceutical Equivalents
0 Views •
2025
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:30
Production of Pharmaceuticals
0 Views •
2026
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
03:18
Nuclear Stability
0 Views •
2020
Protons and neutrons, collectively called nucleons, are packed together tightly in a nucleus. With a radius of about 10−15 meters, a nucleus is quite small compared to the radius of the entire atom, which is about 10−10 meters. Nuclei are extremely dense compared to bulk matter, averaging 1.8 × 1014 grams per cubic centimeter. If the earth’s density were equal to the average nuclear density, the earth’s radius would be only about 200 meters. To hold positively charged protons together in the...
FAQs
These factors can alter the rates or pathways of chemical degradation. Temperature, moisture, and pH affect how formulation components participate in reactions, while light and oxygen can promote photolysis or oxidation. Their effects may occur together rather than independently, so stability evaluations examine controlled environmental conditions to identify which variables most strongly influence product quality.
Hydrolysis, oxidation, and photolysis represent different degradation pathways that can reduce the quality of a pharmaceutical product. Hydrolysis is associated with the influence of moisture, oxidation with oxygen-related reactions, and photolysis with light exposure. Distinguishing these pathways helps explain observed changes in the active pharmaceutical ingredient and supports more appropriate formulation and packaging decisions.
Formulation components can influence how readily an active pharmaceutical ingredient undergoes degradation, while pH can affect the chemical conditions in which those reactions occur. Stability studies therefore examine more than the drug substance alone: they also monitor excipients and the finished formulation. This approach helps identify combinations that better preserve strength, purity, and overall product quality.
Researchers store the drug substance or product under defined conditions and monitor changes over time. Measurements may include the active pharmaceutical ingredient, excipients, dissolution, and degradation products. Comparing these results across conditions reveals whether chemical or performance attributes change during storage and provides evidence for selecting suitable formulation, packaging, and storage strategies.
Observed changes during controlled stability studies help establish how long a product can maintain its required quality and what storage conditions should be recommended. Results concerning strength, purity, dissolution, and degradation products are considered together rather than relying on a single measurement. The resulting guidance connects chemical behavior during storage with practical expectations for product use.
In chemistry, stability evaluation connects environmental conditions and formulation composition with specific degradation reactions. In pharmaceutical development, those findings guide formulation design, packaging selection, and compliance with regulatory quality standards. The work also supports safe, effective delivery by identifying whether a medicine retains the properties needed to perform acceptably throughout storage and use.